Study Evaluating the Pharmacokinetics of HCV-796 in Healthy Japanese Men

Wyeth

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: HCV-796

Study type: Interventional

Funder types: Industry

Identifiers

NCT00385190

3173A1-108

Details and patient eligibility

About

The purpose of the study is to assess the safety and tolerability of ascending multiple oral doses of HCV-796 in healthy Japanese male subjects.

Sex: Male

Ages: 20 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead ECG.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind